Mental health policy and practice across Europe: an overview

Table 7.12 Europe by drug type and country: anxiolytics
Anxiolytics (SU per 1000 population)
1993 1994 1995 1996 1997 1998 1999 2000 2001 2002
Austria 12,140 11,792 11,514 11,540 12,087 12,292 12,422 12,429 12,451 12,411
Belgium 38,609 37,337 36,965 37,484 38,391 38,830 39,035 39,034 38,778 38,583
Denmark* – – – – – – – – – –
Finland 19,927 20,258 20,350 20,457 20,631 21,006 20,972 21,297 21,656 22,201
France 46,599 45,363 43,801 42,559 41,513 41,067 39,957 40,460 41,101 39,960
Germany 9,583 9,312 9,205 9,065 8,801 8,703 8,534 8,868 8,609 7,719
Greece*** 17,380 16,684 16,484 18,118 16,833 17,416 18,739 18,862 19,299 21,682
Ireland*** 12,284 12,815 13,276 14,065 14,337 14,788 14,434 15,813 16,237 16,400
Italy 22,549 22,457 23,444 24,172 23,844 23,758 23,841 24,002 24,044 23,416
Luxembourg*** 26,663 26,367 28,375 29,531 30,862 32,506 32,119 31,156 31,265 31,530
Netherlands** – – – – – – – – 16,862 16,643
Portugal*** 44,938 48,532 49,823 52,499 52,274 53,551 56,073 58,210 59,414 59,131
Spain** 21,657 22,974 24,726 26,498 28,674 30,363 32,891 34,756 36,403 37,824
Sweden* – – – – – – – – – –
United Kingdom 6,848 6,545 6,706 6,973 7,174 7,406 7,496 6,887 7,031 6,960
* No IMS data available.
** No IMS data available for Spain (hospital) until 1999 and from Netherlands (retail) until 2000.
*** Data from retail panels only.
Source: IMS Health Third Study. See Note 1.